Year: 2020

news_6

BeiGene Announces the Approval in China of BLINCYTO® (Blinatumomab) for Injection for Adult Patients with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (ALL)

BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--$BGNE #BGNE--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing...

pressrelease_464807_1607094863

New and Unique Service from Cryptoscamalert.com. Users Can Not Just Report Crypto Frauds But Also Check Potential Partners Before Even Making an Investment.

As many already know, it is highly recommended to check the Cryptoscamalert.com database before investing in cryptocurrency. There are hundreds...